Cargando…

The clinicopathological significance and drug target potential of FHIT in breast cancer, a meta-analysis and literature review

FHIT is a bona fide tumor-suppressor gene and its loss contributes to tumorigenesis of epithelial cancers including breast cancer (BC). However, the association and clinicopathological significance between FHIT promoter hypermethylation and BC remains unclear. The purpose of this study is to conduct...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Yunshu, Wang, Xiaoli, Li, Jun, Xu, Junming, Xu, Lijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598219/ https://www.ncbi.nlm.nih.gov/pubmed/26491255 http://dx.doi.org/10.2147/DDDT.S89861

Ejemplares similares

The clinicopathological significance of FHIT hypermethylation in non-small cell lung cancer, a meta-analysis and literature review
por: Yan, Wei, et al.
Publicado: (2016)

The clinicopathological significance and ethnic difference of FHIT hypermethylation in non-small-cell lung carcinoma: a meta-analysis and literature review
por: Wu, Xiaoyu, et al.
Publicado: (2016)

Clinicopathological significance and potential drug target of RUNX3 in non-small cell lung cancer: a meta-analysis
por: Xu, Lijun, et al.
Publicado: (2015)

Restored expression of Fhit protein in Fhit-minus breast cancer cells
por: Campiglio, M, et al.
Publicado: (2001)

Clinicopathological significance and potential drug target of CDH1 in breast cancer: a meta-analysis and literature review
por: Huang, Ruixue, et al.
Publicado: (2015)

Association of FHIT expression and FHIT gene hypermethylation with liver cancer risk: a PRISMA-compliant meta-analysis
por: Zhang, Yaping, et al.
Publicado: (2017)

Clinicopathological significance and potential drug target of RUNX3 in breast cancer
por: Yu, Ying-Ying, et al.
Publicado: (2014)

Clinicopathological significance and potential drug targeting of CDH1 in lung cancer: a meta-analysis and literature review
por: Yu, Qiaowen, et al.
Publicado: (2015)

Clinicopathological significance and potential drug target of T-cadherin in NSCLC
por: Wang, Zhidong, et al.
Publicado: (2014)

FHIT gene and cancer.
Publicado: (1996)

Analysis of Fhit expression in stages of breast cancer progression
por: Campiglio, M, et al.
Publicado: (2000)

The association of CXCR4 expression with clinicopathological significance and potential drug target in prostate cancer: a meta-analysis and literature review
por: Chen, Qi, et al.
Publicado: (2015)

FHIT Doubts are Clear Now
por: Wali, Anjilna
Publicado: (2010)

The expression of FHIT, PCNA and EGFR in benign and malignant breast lesions
por: Terry, G, et al.
Publicado: (2007)

Clinicopathological Significance and Potential Drug Target of CDKN2A/p16 in Endometrial Carcinoma
por: Su, Li, et al.
Publicado: (2015)

Loss of Fhit expression in non-small-cell lung cancer: correlation with molecular genetic abnormalities and clinicopathological features
por: Geradts, J, et al.
Publicado: (2000)

Effects of FHIT gene on proliferation and apoptosis of osteosarcoma cells
por: Xu, Zhengfeng, et al.
Publicado: (2019)

Aberrant FHIT transcripts in hepatocellular carcinomas.
por: Chen, Y. J., et al.
Publicado: (1998)

The Fhit protein: an opportunity to overcome chemoresistance
por: Gaudio, Eugenio, et al.
Publicado: (2016)

Clinicopathological significance and potential drug target of p15(INK4B) in multiple myeloma
por: Li, Jun, et al.
Publicado: (2014)

Tanshinones induce tumor cell apoptosis via directly targeting FHIT
por: Zhou, Xianglian, et al.
Publicado: (2021)

Abnormalities of the FHIT gene in human oral carcinogenesis
por: Tanimoto, K, et al.
Publicado: (2000)

Evaluation of FHIT gene alterations in ovarian cancer.
por: Buttitta, F., et al.
Publicado: (1998)

Alternative Splicing of the FHIT Gene in Colorectal Cancers
por: Hibi, Kenji, et al.
Publicado: (1997)

Abnormalities of the FHIT Transcripts in Osteosarcoma and Ewing Sarcoma
por: Hinohara, Shin‐ichi, et al.
Publicado: (1998)

Clinicopathological and prognostic significance of COX-2 immunohistochemical expression in breast cancer: a meta-analysis
por: Xu, Feng, et al.
Publicado: (2016)

Analysis of chromosome alterations and the E-cadherin and FHIT genes in lobular breast cancer
por: Ingvarsson, S, et al.
Publicado: (2000)

Multiple Patterns of FHIT Gene Homozygous Deletion in Egyptian Breast Cancer Patients
por: Ismail, Heba M. S., et al.
Publicado: (2011)

Gene expression of WWOX, FHIT and p73 in acute lymphoblastic leukemia
por: CHEN, XU, et al.
Publicado: (2013)

Impaired FHIT expression characterizes serous ovarian carcinoma
por: Ozaki, K, et al.
Publicado: (2001)

Fhit loss‐associated initiation and progression of neoplasia in vitro
por: Karras, Jenna R., et al.
Publicado: (2016)

Effect of interventional embolotherapy on FHIT and p16 expression in hepatocellular carcinoma patients
por: Xu, Wei, et al.
Publicado: (2019)

Meta-analysis of the clinicopathological significance of miRNA-145 in breast cancer
por: Lv, Peng, et al.
Publicado: (2020)

The clinicopathological significance of neurogenesis in breast cancer
por: Zhao, Qianqian, et al.
Publicado: (2014)

FHIT基因启动子甲基化与肺癌相关性的meta分析
Publicado: (2014)

The association of HMGB1 expression with clinicopathological significance and prognosis in Asian patients with colorectal carcinoma: a meta-analysis and literature review
por: Zhang, Xiaoli, et al.
Publicado: (2016)

Impact of FHIT loss on the translation of cancer-associated mRNAs
por: Kiss, Daniel L., et al.
Publicado: (2017)

FHIT as a biomarker for early screening of adult T-cell leukemia
por: Bellon, Marcia, et al.
Publicado: (2021)

The clinicopathological significance of Mortalin overexpression in invasive ductal carcinoma of breast
por: Jin, Haidan, et al.
Publicado: (2016)

The Clinicopathological Significance of MicroRNA-155 in Breast Cancer: A Meta-Analysis
por: Zeng, Hui, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_31mhhkbnv4k33q3dfb4n4bav4k